![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Vuab Pharma A.s. Roztoky Cz, based in Czech Republic, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Dacarbazine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-330 - Rev 02
This Chemical Type CEP, issued on May 26, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1691 associated with this CEP further emphasizes